Effects of consultations and interventions in a pharmacist-led outpatient clinic on duration of treatment and adverse events with osimertinib
Journal of Oncology Pharmacy Practice
Published online on March 29, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
PurposeOsimertinib, which is a key treatment for patients with epidermal growth factor receptor gene mutation-positive non-small cell lung cancer (EGFR mt NSCLC), causes intractable adverse events for some patients. The objective of this study was to ...
PurposeOsimertinib, which is a key treatment for patients with epidermal growth factor receptor gene mutation-positive non-small cell lung cancer (EGFR mt NSCLC), causes intractable adverse events for some patients. The objective of this study was to ...